HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hemagglutination inhibition antibodies in congenital rubella syndrome. A 17-year follow-up in the Ryukyu Islands.

Abstract
We studied long-term rubella hemagglutination inhibition (HI) antibody titers in 381 children born between 1965 and 1966 with congenital rubella syndrome and in 344 of their mothers, who had had postnatally acquired rubella infection. Serum specimens were obtained 12 times during a 17-year period. The initial geometric mean titer of the rubella HI antibody was higher in the children than in their mothers, but the titer declined more rapidly in the children. After 17 years it was 2(5.4) in the children and 2(6.9) in the mothers. In 13 (3.4%) of the children, the rubella HI antibody titer reverted to negativity after three to 17 years. None of the mothers showed a reversion.
AuthorsK Ueda, K Tokugawa, J Fukushige, H Yoshikawa, S Nonaka
JournalAmerican journal of diseases of children (1960) (Am J Dis Child) Vol. 141 Issue 2 Pg. 211-2 (Feb 1987) ISSN: 0002-922X [Print] UNITED STATES
PMID3812390 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
Topics
  • Adolescent
  • Adult
  • Antibodies, Viral (immunology)
  • Child
  • Follow-Up Studies
  • Hemagglutination Inhibition Tests
  • Humans
  • Japan
  • Rubella (immunology)
  • Rubella Syndrome, Congenital (immunology)
  • Rubella virus (immunology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: